Literature DB >> 25656572

MicroRNAs let-7b/i suppress human glioma cell invasion and migration by targeting IKBKE directly.

Yuan Tian1, Shaobo Hao1, Minhua Ye2, Anling Zhang3, Yang Nan4, Guangxiu Wang3, Zhifan Jia3, Kai Yu4, Lianmei Guo4, Peiyu Pu3, Qiang Huang5, Yue Zhong6.   

Abstract

We demonstrated that IKBKE is overexpressed in human gliomas and that the downregulation of IKBKE markedly inhibits the proliferative and invasive abilities of glioma cells, which is consistent with the results reported by several different research groups. Therefore, IKBKE represents a promising therapeutic target for the treatment of glioma. In the present study, we verified that the microRNAs let-7b and let-7i target IKBKE through luciferase assays and found that let-7b/i mimics can knock down IKBKE and upregulate E-cadherin through western blot analysis. Moreover, the expression levels of let-7b/i were significantly lower in glioma cell lines than that in normal brain tissues, as determined by quantitative real-time PCR. Furthermore, let-7b/i inhibit the invasion and migration of glioma cells, as determined through wound healing and Transwell assays. The above-mentioned data suggest that let-7b/i inhibit the invasive ability of glioma cells by directly downregulating IKBKE and indirectly upregulating E-cadherin.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  E-cadherin; Glioma; IKBKE; Let-7b/i

Mesh:

Substances:

Year:  2015        PMID: 25656572     DOI: 10.1016/j.bbrc.2015.01.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

2.  * Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia.

Authors:  Anthony Monteforte; Brian Lam; Michael B Sherman; Kayla Henderson; Andrew D Sligar; Adrianne Spencer; Brian Tang; Andrew K Dunn; Aaron B Baker
Journal:  Tissue Eng Part A       Date:  2017-11       Impact factor: 3.845

3.  Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer.

Authors:  Zhen Zhao; Yuanke Li; Hao Liu; Akshay Jain; Pratikkumar Vinodchandra Patel; Kun Cheng
Journal:  Sci Adv       Date:  2020-07-15       Impact factor: 14.136

4.  Let-7b inhibits the malignant behavior of glioma cells and glioma stem-like cells via downregulation of E2F2.

Authors:  Hang Song; Yao Zhang; Na Liu; Dongdong Zhang; Chao Wan; Sheng Zhao; Yan Kong; Liudi Yuan
Journal:  J Physiol Biochem       Date:  2016-08-13       Impact factor: 4.158

5.  Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.

Authors:  Xuhui Lei; Liang Chang; Wei Ye; Chuanlu Jiang; Zhiren Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

6.  A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells.

Authors:  Lobna Elkhadragy; Minyi Chen; Kennon Miller; Muh-Hwa Yang; Weiwen Long
Journal:  Mol Oncol       Date:  2017-01-12       Impact factor: 6.603

7.  IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway.

Authors:  Jie Lu; Yi Yang; Gaochao Guo; Yang Liu; Zhimeng Zhang; Shicai Dong; Yang Nan; Zhenyi Zhao; Yue Zhong; Qiang Huang
Journal:  Oncotarget       Date:  2017-07-25

8.  let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1.

Authors:  M-M Qin; X Chai; H-B Huang; G Feng; X-N Li; J Zhang; R Zheng; X-C Liu; C Pu
Journal:  BMC Urol       Date:  2019-06-13       Impact factor: 2.264

9.  Decreased let-7b is associated with poor prognosis in glioma.

Authors:  Wanzeng Zhang; Wangmiao Zhao; Chunyan Ge; Xiaowei Li; Xuehui Yang; Yi Xiang; Zhaosheng Sun
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

10.  MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.

Authors:  Tie Liu; Anqi Li; Yulun Xu; Yu Xin
Journal:  Cancer Med       Date:  2019-01-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.